Qinyu Ge

Prof. Qinyu Ge

School of biological and medical engineering, Southeast University, Nanjing, Jiangsu, China
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2014 in Molecules
Verified
Journal Article
Open access
PDF file
QGQinyu Ge
Qinyu Ge
YZYouxia Zhou
Youxia Zhou
JLJiafeng Lu
Jiafeng Lu
YBYunfei Bai
Yunfei Bai
XXXueying Xie
Xueying Xie
ZLZuhong Lu
Zuhong Lu
Exosomes are small membrane-bound vesicles secreted by most cell types. Exosomes contain various functional proteins, mRNAs and microRNAs (miRNAs) that could be used for diagnostic and therapeutic purposes. How we should store the samples before RNA isolation and whether those long term stored samples could be used for circulating RNA investigation because of RNase is unknown. The aim of the study was to determine the stability of circulating miRNA in exosomes and plasma. Exosomes were isolated from plasma samples by using ExoQuick Precipitation methods. RNA was extracted from exosomes and the corresponding plasma samples with a Qiagen miRNeasy Mini kit. The concentration of RNA was measured by a Qubit® RNA HS Assay Kit, and quantitative PCR was used for individual miRNA expression level detection. Results showed that exosomal miRNA showed extra stability under different storage conditions and no significant influence on plasma miRNA, except for short term storage at 4 °C. It is thus indicated that exosome miRNAs can be good biomarkers based on their stability under various storage conditions.

23 March 2015 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
YZYanan Zhu
Yanan Zhu
FTFei Tian
Fei Tian
HLHailing Li
Hailing Li
YZYouxia Zhou
Youxia Zhou
JLJiafeng Lu
Jiafeng Lu
QGQinyu Ge
Qinyu Ge

1 January 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HLHailing Li
Hailing Li
QGQinyu Ge
Qinyu Ge
LGLi Guo
Li Guo
ZLZuhong Lu
Zuhong Lu
Objective. Preeclampsia (PE) is a pregnancy-specific syndrome and one of the leading causes of maternal and fetal morbidity and mortality. The pathophysiological mechanisms of PE remain poorly known. Recently, circulating miRNAs are considered as potential useful noninvasive biomarkers. The aim of this study was to identify differentially expressed plasma miRNAs in preeclamptic pregnancies compared with normal pregnancies.Methods. Maternal plasma miRNA expression profiles were detected by SOLiD sequencing. Differential expressions between mPE/sPE and control group were found. Next, four differentially expressed plasma miRNAs were chosen to validate their expression in other large scale samples by real-time PCR.Results. In terms of sequencing results, we identified that 51 miRNAs were differentially expressed. Four differentially expressed plasma miRNAs (miR-141, miR-144, miR-221, and miR-29a) were selected to validate the sequencing results. RT-PCR data confirmed the reliability of sequencing results. The further statistical analysis showed that maternal plasma miR-141 and miR-29a are significantly overexpressed in mPE (P<0.05). Maternal plasma miR-144 is significantly underexpressed in mPE and sPE (P<0.05).Conclusions. Results showed that there were differentially expressed maternal plasma miRNAs in patients with preeclampsia. These plasma miRNAs might be used as notable biomarkers for diagnosis of preeclampsia.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HSHua-Juan Shi
Hua-Juan Shi
YZYing Zhou
Ying Zhou
EJErteng Jia
Erteng Jia
MPMin Pan
Min Pan
YBYunfei Bai
Yunfei Bai
QGQinyu Ge
Qinyu Ge
Although RNA sequencing (RNA‐seq) has become the most advanced technology for transcriptome analysis, it also confronts various challenges. As we all know, the workflow of RNA‐seq is extremely complicated and it is easy to produce bias. This may damage the quality of RNA‐seq dataset and lead to an incorrect interpretation for sequencing result. Thus, our detailed understanding of the source and nature of these biases is essential for the interpretation of RNA‐seq data, finding methods to improve the quality of RNA‐seq experimental, or development bioinformatics tools to compensate for these biases. Here, we discuss the sources of experimental bias in RNA‐seq. And for each type of bias, we discussed the method for improvement, in order to provide some useful suggestions for researcher in RNA‐seq experimental.

1 July 2012 in Clinica Chimica Acta
Verified
Journal Article
Closed access
QWQian Wu
Qian Wu
CWChao Wang
Chao Wang
ZLZuhong Lu
Zuhong Lu
LGLi Guo
Li Guo
QGQinyu Ge
Qinyu Ge

1 January 2011 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QWQian Wu
Qian Wu
ZLZuhong Lu
Zuhong Lu
HLHailing Li
Hailing Li
JLJiafeng Lu
Jiafeng Lu
LGLi Guo
Li Guo
QGQinyu Ge
Qinyu Ge
It is reported that different microRNA (miRNA) profiles can be detected in the blood of cancer patients. We investigated that whether the key serum miRNAs could discriminate patients with and without breast cancer. This study was divided into three parts: (1) miRNA marker discovery using SOLiD sequencing‐based miRNA profiling on cancerous and adjacent noncancerous breast tissue of one breast cancer patient; (2) marker selection and validation by real‐time PCR on a small set of serum; (3) gene ontology analysis of the key miRNA target genes. Of genome‐wide tissue miRNA expression analysis, five miRNAs were found to be altered more than fivefold by SOLiD sequencing (i.e., miR‐29a, miR‐23a, miR‐23b, miR‐192, and miR‐21). All the five miRNAs were validated on the 20 breast cancer patients and 20 controls. miR‐29a and miR‐21 were significantly increased in the serum of breast cancer patients (P < .05). Gene ontology analysis of the target genes revealed enrichment for special biological process categories, that is, signal transduction, development, apoptosis, cell proliferation, and cell adhesion. SOLiD sequencing provides a promising method for cancer‐related miRNA profiling. Serum miRNAs may be useful biomarkers for breast cancer detection.